Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort Varga, Zsuzsanna; Li, Qiyu; Jochum, Wolfram; Perriard, Ulrike; ... Ruhstaller, Thomas 2019
add to browser selection
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer Yan, Pu; Klingbiel, Dirk; Saridaki, Zenia; Ceppa, Paola; ... Fiocca, Roberto 2016
add to browser selection
Single Nucleotide Polymorphism (rs4932178) in the P1 Promoter of FURIN Is Not Prognostic to Colon Cancer Declercq, Jeroen; Jacobs, Bart; Biesmans, Bart; Roth, Arnaud; ... Creemers, John W 2015
add to browser selection
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) Templeton, Arnoud J; Dutoit Vallotton, Valérie; Cathomas, Richard; Rothermundt, Christian; ... Gillessen, Silke 2013
add to browser selection
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma Renner, Christoph; Zinzani, Pier Luigi; Gressin, Rémy; Klingbiel, Dirk; ... Ketterer, Nicolas 2012
add to browser selection
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial Roth, Arnaud; Tejpar, Sabine; Delorenzi, Mauro; Yan, Pu; ... Bosman, Fred 2010